, net - 67 -100.0 - 173 -100.0 NCI - (3) 100.0 (3) (12) 75.0 Profit attributable to Equity holders of the Company 152 3,118 -95.1 660 3,977 -83.4 Basic earnings per share (Baht) 0.01 0.20 0.04 0.26
or 11.5% from increase in net profit resulting to increase in unappropriated retained earnings. Please be informed accordingly, Yours sincerely, (Mr.Tanavijit Ankapipatchai) Director and Chief
on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
Consolidated Financial Statement (Unit: Million Baht) 2020 2019 YOY Million Baht % Sales and Services 366.78 1,329.58 (962.80) (72.41%) Gross Profit 87.30 131.58 (44.28) (33.65%) Other Income 87.83 18.63 69.20
66% (18%) 1,415 1,549 9% Net profit 2,326 2,928 2,530 9% (14%) 13,568 11,216 (17%) Excluding non-recurring items 2,151 2,620 2,445 14% (7%) 9,893 10,823 9% Earnings per basic share (THB) 0.52 0.65 0.56
66% (18%) 1,415 1,549 9% Net profit 2,326 2,928 2,530 9% (14%) 13,568 11,216 (17%) Excluding non-recurring items 2,151 2,620 2,445 14% (7%) 9,893 10,823 9% Earnings per basic share (THB) 0.52 0.65 0.56
business operations, having main proportional sale is export. 1.2 Summary of operating results. For the year ending 31 December 2017, the Company had net profit amounting 42.91 million Baht, profit increased
0.03 4.58 (99.34) 0.03 - 0.10 12.60 (99.21) Income tax expenses 4.25 8.39 (49.34) 5.34 (20.41) 15.05 26.23 (42.62) Net profit 17.39 30.55 (43.08) 20.89 (16.75) 60.96 99.51 (38.74) Earnings before
29% 30% Net foreign exchange gains (losses)2 (52) 111 (30) (127%) (42%) Net profit 1,250 1,420 1,658 17% 33% Non-controlling interests (308) (275) (78) (72%) (75%) Net profit for the company 942 1,145
declining in revenue from sales and lower share of profit from associated companies. Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA) The consolidated EBITDA in 2Q2018 was THB 631.26